Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INCY | AMGN | BMY | GILD | VRTX |
| Company | Incyte Corp | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 53.79 | 301.00 | 43.90 | 65.33 | 405.97 |
| High | 54.19 | 301.00 | 43.90 | 65.33 | 405.97 |
| Low | 53.45 | 301.00 | 43.90 | 65.33 | 405.97 |
| Last | 54.08 | 301.00 | 43.90 | 65.33 | 405.97 |
| Change | +0.32 | +1.52 | unch | -0.21 | +3.47 |
| % Change | +0.60% | +0.51% | unch | -0.32% | +0.86% |
| Volume | 2,016,500 | 1,987 | 5,752 | 1,027 | 1,088 |
| 20-Day Average Volume | 2,047,185 | 2,701,694 | 13,833,763 | 7,240,006 | 1,021,884 |
| Previous Close | 53.76 | 299.48 | 43.90 | 65.54 | 402.50 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 53.01 | 275.32 | 46.72 | 66.46 | 398.42 |
| 20-Day Raw Stochastic | 61.05% | 65.12% | 7.13% | 18.47% | 90.23% |
| 20-Day Relative Strength | 46.88% | 63.34% | 29.02% | 34.07% | 51.30% |
| Weighted Alpha | -17.28 | +28.54 | -36.38 | -20.35 | +16.28 |
| Today's Opinion | 88% Sell | 40% Buy | 100% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 88% Sell | 24% Buy | 100% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 100% Sell | 24% Sell | 32% Sell | 100% Sell | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.89% since 04/29/24 | +9.88% since 04/30/24 | -0.09% since 04/30/24 | +0.20% since 04/30/24 | +3.35% since 04/30/24 |
| Low | 50.35 on 04/30/24 | 273.38 on 05/01/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 392.47 on 05/01/24 |
| High | 54.19 on 05/06/24 | 322.60 on 05/03/24 | 44.62 on 05/06/24 | 65.89 on 05/01/24 | 407.59 on 05/06/24 |
| 1-Month | |||||
| %Chg | -2.10% since 04/05/24 | +11.50% since 04/05/24 | -14.46% since 04/05/24 | -6.10% since 04/05/24 | -0.17% since 04/05/24 |
| Low | 50.35 on 04/30/24 | 260.68 on 04/19/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 56.46 on 04/09/24 | 322.60 on 05/03/24 | 51.68 on 04/09/24 | 69.95 on 04/09/24 | 407.59 on 05/06/24 |
| 3-Month | |||||
| %Chg | -9.31% since 02/06/24 | +1.73% since 02/07/24 | -9.75% since 02/07/24 | -12.21% since 02/07/24 | -3.13% since 02/07/24 |
| Low | 50.35 on 04/30/24 | 260.68 on 04/19/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 61.87 on 02/23/24 | 322.60 on 05/03/24 | 55.03 on 03/13/24 | 76.21 on 03/11/24 | 437.00 on 02/27/24 |
| 6-Month | |||||
| %Chg | -0.90% since 11/06/23 | +11.03% since 11/07/23 | -16.05% since 11/07/23 | -18.95% since 11/07/23 | +7.33% since 11/07/23 |
| Low | 50.35 on 04/30/24 | 260.52 on 11/21/23 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 341.90 on 11/16/23 |
| High | 67.36 on 01/04/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 12,143,178 | 160,633,888 | 88,989,688 | 81,602,352 | 104,029,752 |
| Shares Outstanding, K | 224,541 | 536,376 | 2,027,100 | 1,245,077 | 258,459 |
| Annual Sales | 3,695,650,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | 597,600,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 880,890,000 | 7,447,000,000 | 11,865,000,000 | 6,686,000,000 | 2,517,700,000 |
| Last Quarter Net Income | 169,550,000 | -113,000,000 | -11,911,000,000 | -4,170,000,000 | 968,800,000 |
| 60-Month Beta | 0.69 | 0.60 | 0.45 | 0.22 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.64 on 04/30/24 | 3.96 on 05/02/24 | -4.40 on 04/25/24 | -1.32 on 04/25/24 | 4.76 on 05/06/24 |
| Latest Earnings Date | 04/30/24 | 05/02/24 | 04/25/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 18.67 | 16.71 | 41.90 | 16.07 | 29.84 |